Takis presented new data about the canine clinical trial conducted in collaboration with Dr Impellizeri, Veterinary Oncology Services (VOS), New York, USA (www.petcancerinformation.com/) at the “XIIth NIBIT Meeting- Cancer Bio-Immunotherapy in Siena".

The improved Overall Survival is associated to biomarkers, such as Telomerase expression and antibody titer. "we are proud of the collaboration with Dr Impellizeri, the results achieved so far and the science behind them. We are happy to contributing to the creation of an option to our best frinds and look forward to extending our cancer vaccines to humans" -  declared Dr Aurisicchio at the end of the presentation.